Zevia Q3 2026 net sales rise 18.4% to $48.3 million; full-year sales outlook raised
Zevia reported third quarter 2026 results on November 4, 2026, with net sales up 18.4% to $48.3 million and net loss narrowing to $2.2 million, or $0.03 per share. The company raised its 2026 net sales guidance to $177 million to $179 million and its Adjusted EBITDA outlook to between breakeven and a loss of $0.4 million, and it disclosed a $20 million growth equity agreement with GP Investments.
Key points
- Net sales rose 18.4% year over year to $48.3 million from $40.8 million, with volume up 14.4%.
- Net loss was $2.2 million, or $0.03 per share, compared with a net loss of $2.8 million in the third quarter of 2025.
- 2026 net sales guidance now $177 million to $179 million; fourth quarter net sales expected at $37.5 million to $39.5 million.
- On October 22, 2026, Zevia agreed to issue convertible preferred stock to a fund managed by GP Investments Ltd. for $20 million of growth equity.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.